Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts
Boehringer Ingelheim

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Amdoxovir

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Amdoxovir: Sponsors, patents, clinical trial progress

Amdoxovir is an investigational drug.

There have been 5 clinical trials for Amdoxovir. The most recent clinical trial was a Phase 2 trial.

The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Virus Diseases. The leading clinical trial sponsors are RFS Pharma, LLC, National Institute of Allergy and Infectious Diseases (NIAID), and [disabled in preview].

Recent Clinical Trials for Amdoxovir
A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced SubjectsRFS Pharma, LLCPhase 2
A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.RFS Pharma, LLCPhase 2
Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIVRFS Pharma, LLCPhase 1/Phase 2

See all Amdoxovir clinical trials

Clinical Trial Summary for Amdoxovir

Top disease conditions for Amdoxovir
Top clinical trial sponsors for Amdoxovir

See all Amdoxovir clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.